Background and objective Remifentanil is being increasingly used as an analgesic in fast-track surgery, but severe postoperative pain may happen occasionally. In this study, we evaluated the effects of systemic administration of lidocaine on postoperative pain and morphine requirements after propofol-remifentanil-based anaesthesia.
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Background and objective Remifentanil is being increasingly used as an analgesic in fast-track surgery, but severe postoperative pain may happen occasionally. In this study, we evaluated the effects of systemic administration of lidocaine on postoperative pain and morphine requirements after propofol-remifentanil-based anaesthesia.
Methods Forty patients undergoing thoracic surgery were randomly assigned to lidocaine (33.0 mg kg S1 min S1 ) and physiological saline control groups in propofolremifentanil-based anaesthesia. The setting of the plasma concentration (C p ) of the target-controlled infusion of propofol was adjusted according to the bispectral index of the electroencephalogram and blood pressure. The C p and effect-site concentration (C e ) of propofol were calculated by target-controlled infusion pump during the intraoperative period. Pain scoring includes a four-point verbal rating scale, Riker's sedation-agitation scale and a visual analogue scale; the morphine requirement in the postanaesthesia care unit and the morphine consumption via a patient-controlled analgesia device on the ward were recorded during the postoperative period.
Results Morphine requirements within 30, 30-60 and 0-120 min in the postanaesthesia care unit of the lidocaine group decreased significantly (P < 0.05, n U 20 per group) compared with that of the control group. The four-point verbal rating scale at 30 min in the postanaesthesia care unit, visual analogue scale at 6 h on coughing and patient-controlled analgesia morphine consumption during 2-6 h postoperative time were also significantly (P < 0.05, n U 20 per group) reduced in the lidocaine group. In addition, the intraoperative propofol C e in the lidocaine group during the periods of intubation, organ resection, closing of chest cavity and extubation was significantly lower (P < 0.05, n U 20 per group) than that in the control group under the same hypnotic depth.
Introduction
With the introduction of the novel m-opioid receptor agonist remifentanil, anaesthesiologists have acquired a unique tool to provide adequate, titratable and predictable analgesia throughout surgery, and decrease the risk of opioid-related delay in postoperative recovery. Although Lee et al. [1] reported that the substitution of 70% nitrous oxide with remifentanil for colorectal surgery did not affect postoperative opioid consumption, major surgery with remifentanil-based anaesthesia is occasionally associated with acute postoperative hyperalgesia, which reduces perioperative safety and patients' satisfaction with anaesthesia [2] . Therefore, choosing a combination that use the benefits of remifentanil fully and prevent severe postoperative pain has become a main consideration of anaesthesiologists.
Most anaesthesiologists administer long-acting opioids to relieve postoperative pain at the end of surgery, but the analgesic efficiency is still inadequate at times even with large doses of supplementary opioids [2, 3] . In addition to the inadequate analgesia provided by long-acting opioids, their side effects such as severe respiratory depression, nausea and vomiting have to be considered. The accumulated evidence from hyperalgesic studies suggests that remifentanil-induced hyperalgesia may contribute to severe postoperative pain [4, 5] . Thus, some anaesthesiologists have tried coadministrating ketamine to inhibit remifentanil-induced hyperalgesia through blocking N-methyl D-aspartate (NMDA) receptors in the central nervous system [6] , but the well known side effects of ketamine also impede its use. Fortunately, the analgesic and antihyperalgesic effects of the systemic administration of lidocaine have been reported [7] . We designed this study to assess the morphine consumption and pain score in the first 2 h in the postanaesthesia care unit (PACU) and the intraoperative propofol effect-site concentration (C e ), and then postoperative morphine consumption and visual analogue scale (VAS) of pain from 2 to 48 h in patients undergoing thoracic surgery after propofol-remifentanil-based anaesthesia.
Methods
In order to meet ethical standards, the protocol was approved by the Research Ethics Committee of Capital Medical University and is consistent with the Ethical Principles for Medical Research Involving Human Subjects outlined in the Declaration of Helsinki, adopted in October 2000 by the World Medical Association. Written consent was obtained from all informed participants or a legal surrogate. During the period of 1 January to 31 July 2008, 45 patients aged 18-65 years and scheduled to undergo thoracic surgery lasting 3-6 h were enrolled in this study. All of the patients had ASA physical status I or II.
Patients' criteria
Patients were excluded from the study when they had chronic pain state; they took analgesics or had used opioids within 7 days before surgery; they had a history of drug or alcohol abuse, psychiatric disorder or obesity (>130% of ideal body weight); they had acute cardiovascular disorder; they had central nervous system diseases; they could not communicate with the investigator; they had contraindications to propofol, opioids and lidocaine (i.e. allergy, heart block and porphyria); they had contraindications to the self-administration of morphine [i.e. unable to understand the patient-controlled analgesia (PCA) device]; their intraoperative time lasted more than 6 h or their immediate extubation was not planned after surgery.
During the preoperative anaesthetic evaluation, patients were instructed in the use of the PCA pump (APII Pain Management Pump, Baxter, Singapore), the four-point verbal rating scale (VRS-4, 0 ¼ no pain, 1 ¼ slight pain, 2 ¼ moderate pain, 3 ¼ intense or severe pain) and the 100 mm VAS for pain (from 0 ¼ no pain to 100 ¼ worst pain), and were premedicated with 10 mg diazepam orally on the evening before surgery.
Patients' group allocation and intraoperative monitoring As shown in Table 1 , patients were randomly assigned, in a double-blinded manner, into two groups -the control group (n ¼ 20) and the lidocaine group (n ¼ 20). At the beginning of this study, a random-number table was generated to specify the group each patient would be assigned upon entry into the trial. For each patient, an envelope containing the group assignment was prepared, sealed and sequentially numbered. On the morning of surgery and before induction of anaesthesia, a nurse who was not involved in the patient's evaluation opened the envelope and prepared remifentanil, lidocaine and physiological saline solution syringes. The investigators involved in patient management or data collection were also not aware of the group assignment.
On arrival in the operating room, monitoring of the patient was established by means of electrocardiograph (ECG), invasive arterial pressure (IAP), pulse oxygen saturation (SpO 2 ) and bispectral index of the electroencephalogram (BIS monitoring; Aspect A-2000, Aspect Medical Systems Inc., Natick, Massachusetts, USA) and peripheral intravenous access was established. Hydroxyethyl starch 130/0.4 (7 ml kg À1 ) was infused at a rate of 20.0 ml kg À1 h À1 before induction of anaesthesia. A double-lumen endobronchial tube and internal jugular vein catheter were placed after induction. Monitoring during maintenance of anaesthesia included ECG, SpO 2 , IAP, central venous pressure (CVP), end-tidal carbon dioxide concentration (ETCO 2 ), nasopharyngeal temperature, muscle relaxation and urine output. Additional intravenous fluids were also given as deemed appropriate by the anaesthesiologist in charge to maintain the CVP in the range of 6.0-12.0 cmH 2 O and urine output more than 1.0 ml kg À1 h À1 . Intermittent boluses of atropine or ephedrine were given as required to treat bradycardia or persistent hypotension. Nitroglycerol (NTG) boluses or continuous infusions were given in case hypertension occurred at a BIS range of 40-60 or during the emergence period.
Anaesthesia protocol
All patients received intravenous scopolamine 0.3 mg as premedication 20 min before induction of anaesthesia, just at the beginning of fluid infusion. A nurse who was not involved in the patient's evaluation prepared remifentanil, (Fig. 1a) . Rocuronium (0.15 mg kg À1 ) was administered intermittently to maintain sufficient muscle relaxation, which was measured by neuromuscular monitoring. As shown in Table 2 , propofol C p was adjusted every 20 s to maintain the BIS value in the range of 40-60 during the periods of anaesthetic induction and maintenance.
Rocuronium administration was stopped 30 min before the anticipated end of surgery. The propofol infusion was stopped to give a C p of 1.0 mg ml À1 at skin closure according to the TCI pump calculated remaining time. After skin closure, lidocaine/physiological saline and remifentanil were discontinued simultaneously, and residual neuromuscular blockage was antagonized with 0.5 mg intravenous neostigmine and 0.25 mg intravenous atropine. The trachea was extubated when patients responded to verbal commands, spontaneous respiratory rate exceeded 12.0 breaths min À1 , tidal volume exceeded 5.0 ml kg À1 and ETCO 2 was less than 45.0 mmHg.
Patients were transferred to the PACU after tracheal extubation and they remained in the PACU for 2 h. Postoperative pain was treated with morphine. At the patient's demand, boluses of morphine (1.0-2.0 mg, 2 min intervals) were given to keep the VRS-4 score less 
Statistical analysis
Statistical analyses were performed with SPSS13.0 software (SPSS Inc., San Francisco, California, USA) by using the Pearson x 2 test, Mann-Whitney U-test, area under the curve (AUC) with independent samples t-test and repeated measures analysis of variance (RMANOVA) with the Bonferroni test as indicated. Results are presented as number of patients, means AE SD, AUC and median (25th-75th percentiles); a P value less than 0.05 was considered as statistically significant.
Results
Forty-five participants were enrolled in the study, but five patients were excluded from this research (three in the control group and two in the lidocaine group) because the duration of the operation exceeded 6 h. No severe side effects or awareness of the operation procedure were reported at day 7 after surgery. Demographics of the patients were similar in both the lidocaine and control groups ( Table 1) .
Effect of systemic administration of lidocaine on postoperative pain and morphine consumption VRS-4 data were catalogued into two groups: VRS of 1 or less and VRS more than 1. In the lidocaine group, the number of patients with a VRS score of 1 or less (0, no pain and 1, mild pain) was higher (16 vs. 10) , whereas the number of patients with a VRS score of more than 1 (2, moderate and 3, severe pain) was less (4 vs. 10) than the control group at 30 min (P ¼ 0.047, n ¼ 20 per group, Pearson x 2 test), but not at 90 and 120 min after extubation in the PACU. Riker's SAS data were also divided into two parts according to the scores: a SAS of 4 or less (sedated, calm and cooperative, 19 vs. 16) and a SAS of more than 4 (agitated, 1 vs. 4), and no significant differences were observed between the lidocaine and control groups. Effect of systemic administration of lidocaine on propofol usage in the intraoperative period As shown in Fig. 1b , intraoperative propofol C e in the lidocaine group was significantly lower than that in the control group at intubation (P ¼ 0.002), organ resection (P ¼ 0.001), closing of the chest cavity (P ¼ 0.015) and extubation (P ¼ 0.031, n ¼ 20 per group, RMANOVA with Bonferroni test) during the intraoperative period. However, the postoperative complications were similar in both the control and lidocaine groups (data not shown).
Correlation of lidocaine analgesic effect with its serum concentration According to pain, sedation and morphine consumption, the systemic administration of low-dose lidocaine has analgesic effects, but they could be weakened at a serum concentration of lidocaine lower than 0.34 AE 0.18 mg ml À1 after 6 h of postoperative time (Table 3 ). In addition, the mean lidocaine concentration detected was 2.31 AE 0.75 mg ml À1 at the end of surgery, which was lower than the toxic dose (<8.0 mg ml À1 ) [9] ; no patient reported any side effects of lidocaine toxicity such as drowsiness, metal taste, perioral numbness or visual disturbances.
Discussion
Systemic administration of lidocaine can benefit patients in such areas as cerebral protection [10] and analgesic and antihyperalgesic effects [7] ; it can also speed up the return of bowel function after surgery [11] . In this study, there were no significant differences between the total doses of morphine given from 0 to 48 h in the postoperative period, but coadministration of lidocaine with propofol-remifentanil-based anaesthesia could reduce morphine requirements during 6 h of postoperative time In addition, the pharmacokinetic model of propofol is a three-compartment model. As the propofol C e level increased or the anaesthetic time increased, the drug distribution in other tissues would increase and recovery might be delayed. So, under an ideal depth of anaesthesia, a lower C e will result in early recovery from anaesthesia and shorten the stay in the PACU. The reduction in propofol usage and stay in the PACU could help to reduce postoperative costs.
At the end of surgery, all patients in both the lidocaine and control groups extubated rapidly without any delays in recovery. Most patients' SAS scales within 120 min in PACU were 4, which indicated that most of them recovered from anaesthesia smoothly and had adequate analgesic treatment. In the lidocaine group, the morphine consumption and VRS-4 in the PACU as well as the VAS score on coughing and PCA morphine usage at 6 h postoperatively were lower than those in the control group. At these time points, the mean serum concentration of lidocaine in the lidocaine group was 1.13 AE 0.37 and 0.34 AE 0.18 mg ml À1 at 2 and 6 h during the postoperative period, respectively. We, therefore, considered that lidocaine above a serum level of 0.34 mg ml À1 may contribute to reducing severe postoperative pain following propofol-remifentanil-based anaesthesia.
Previous clinical studies [12, 13] have shown contradictory results on lidocaine postoperative analgesic effects. This may be due to the usage of long-acting opioids and inhalation agents as their residual analgesic effects might interfere with the evaluation on lidocaine. In this study, we employed remifentanil as the only anaesthetic and propofol as the sedation agent intraoperatively to avoid potent residual intraoperative analgesia mixed with the lidocaine effect. So the difference in pain status in both groups of this study is mainly related to lidocaine. Studies have demonstrated little effect of intravenous lidocaine on normal pain thresholds but profound effects on hyperalgesia-related phenomena [14] . An in-vivo study [15] indicated that systemic administration of lidocaine can prevent mechanical hyperalgesia and allodynia in a rat incision model. Another in-vitro study [16] demonstrated that lidocaine could inhibit the activation of human NMDA receptors in a concentration-dependent manner. Thus, in this study, we inferred that the clinically analgesic effect of lidocaine on remifentanil-induced postoperative pain may be due to its antihyperalgesic effect.
In this study, we also demonstrated that systemic continuous lidocaine infusion decreases the propofol dosage by about 20% in the intraoperative period. To evaluate the anaesthetic effect of lidocaine, one must keep the hypnotic depth at same level in both groups. BIS monitoring is now popular and credible for noninvasive assessment of hypnotic depth, especially for monitoring the hypnotic effect of propofol. Using the BIS in propofol-based anaesthesia can help decrease the risk of intraoperative awareness and delayed recovery. In the present study, we kept the BIS values of the patients in both groups in the range of 40-60, which was considered to be an ideal depth of hypnosis [17] . In addition, the dose of lidocaine used in this study was similar to the doses used by Cassuto et al. [13] , Groudine et al. [11] and Martin et al. [12] . These results suggested that coadministration of low-dose lidocaine could decrease the propofol usage and maintain the ideal hypnotic depth.
There is a limitation in this study that we could not interpret whether lidocaine attenuates postoperative pain by preventing remifentanil-induced hyperalgesia. Future study protocols should take into account the possibility of remifentanil-induced hyperalgesia. In conclusion, this is the first study to combine lidocaine with propofolremifentanil-based anaesthesia; the results indicate that systemic administration of lidocaine could reduce morphine requirements, postoperative pain and intraoperative propofol C e of patients undergoing thoracic surgery after propofol-remifentanil-based anaesthesia.
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